Community Health Worker-Led Intervention Beneficial in T2DM

Share this content:
Community Health Worker-Led Intervention Beneficial in T2DM
Community Health Worker-Led Intervention Beneficial in T2DM

MONDAY, May 7, 2018 (HealthDay News) -- A community health worker (CHW)-led diabetes self-management education (DSME) program is associated with sustained improvement in hemoglobin A1c (HbA1c), according to a study published online April 27 in Diabetes Care.

Michael S. Spencer, Ph.D., from the University of Michigan in Ann Arbor, and colleagues randomized 222 Latino adults with type 2 diabetes and poor glycemic control to a CHW-led, six-month DSME program or enhanced usual care (EUC). Participants randomized to the CHW-led DSME were further randomized after the program to 12 months of CHW-delivered monthly telephone outreach or 12 months of weekly group sessions delivered by peer leaders (PLs; CHW+PL).

The researchers found that at the six-month follow-up, compared with EUC, participants in the CHW intervention had greater decreases in HbA1c (−0.45) and in diabetes distress (−0.3). Improvements in HbA1c were maintained at 12 and 18 months in CHW+PL participants; CHW-only participants maintained improvements in diabetes distress at 12 and 18 months. Compared with EUC, CHW+PL participants also had significantly fewer depressive symptoms at 18 months (−2.2). Relative to EUC, participants in CHW-led DSME had significant improvements in diabetes social support and in understanding of diabetes self-management at six months; these effects were not maintained at 18 months.

"This study demonstrates the effectiveness of a six-month CHW intervention on key diabetes outcomes and of a volunteer PL program in sustaining key achieved gains," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »